Help us gather key insigths!

This is the second phase survey of NANOMED 2020, dedicated to the analysis and optimization of the nanomedicine value chain and development process,

This survey has been designed to give complementary information to a previous work on establishing the nanomed milestones, with the objectives to:
· identify the main barriers and needs along each step of the value chain, from idea and research all the way to market and commercialisation.

· assess the interplay between the different stakeholders involved and the main differences of perspectives at the key interfaces

· provide all participants with the possibility to comment and endorse the milestones and checklists established so far by the NanoMed2020 consortium

Go to the survey:
https://www.vdivde-it.de/mrIWeb/mrIWeb.dll?I.Project=NANOMED2020_SECOND_PHASE

The aim of this survey is to gather key insights into the nanomedicine development process in order to identify the main barriers and needs along each step of the value chain, from idea and research all the way to market and commercialisation.

Focusing on each relevant category of stakeholder, the data will provide a major opportunity to assess the interplay between the different stakeholders involved and the main differences of perspectives at the key interfaces.

Finally, this survey will provide all participants with the possibility to comment and endorse the milestones and checklists established so far by the NanoMed2020 consortium to ensure successful development and uptake from idea to product on the market.

About NanoMed 2020:The NANOMED2020 Coordination and Support Action under the FP7-Health started in September 2012 for a duration of 18 months and aims at federating the nanomedicine community in Europe and delivering concrete recommendations to the European Commission to push forward the field of nanomedicine under Horizon 2020.